The Leadership Team

Greg Austin is President of PCM Trials and has led the company to become a global leader in decentralized clinical trials since its inception in 2008. He also serves as President of Professional Case Management (PCM), a national provider of specialty mobile nurse visits. Leveraging over 30 years of institutional knowledge from PCM, Mr. Austin introduced many best practices of mobile nurse visits to the clinical research industry, enabling the widespread adoption of decentralized clinical trials utilizing nurse visits to participants’ homes. He further evolved a robust shared services structure with PCM, deploying the infrastructure of a large mobile nurse visit company to support direct-to-patient clinical research needs. Mr. Austin’s visionary leadership enabled PCM Trials to scale up dramatically during the Covid pandemic to support sponsors and CROs worldwide, and many of PCM Trials’ innovations have been adopted as standard practices today for decentralized clinical trials.

Prior to joining PCM Trials, Mr. Austin served as a senior leader of strategy and corporate development at Dex Media where he was responsible for developing and driving digital growth strategies. He started his career with Computer Sciences Corp., where he led healthcare and life sciences engagements driving operational efficiencies, improving quality of care, and streamlining systems to maximize profitability.

Mr. Austin earned a Bachelor of Science in Business Administration from Metropolitan State University and a Master of Business Administration from the University of Colorado.

Hollis Baugh is the Vice President of Compliance and Compliance Officer. Mr. Baugh joined PCM in 2019 and leads the quality, compliance, and audit functions to adhere to the highest data quality standards for the clinical research industry.

Mr. Baugh augmented PCM Trials’ clinical research quality standards by increasing internal and customer facing governance structure, enhancing audit and escalation infrastructure, and strict adherence to clinical research industry standards. He spearheaded the buildout of a comprehensive GDPR program, and continues to fortify privacy-by-design throughout the PCM Trials. Governed by the Company’s security framework (CIS 20), he instituted an industry leading data privacy standard for protecting highly sensitive clinical trials data as well as those of trial participants.

Prior to joining PCM, Mr. Baugh oversaw the buildout of a comprehensive HIPAA program for OrthoFi, a Denver healthcare company as Compliance Officer. Previously, he held a variety of leadership roles in financial services companies including SquareTwo Financial and Western Union.

Mr. Baugh earned a Bachelor of Arts in Psychology from the University of Texas, and a Master of Business Administration from the University of Colorado.

Brad Drevno is the Chief Operating Officer. Mr. Drevno joined PCM in 2016 bringing over 30 years of executive leadership and operational experience.

Prior to joining PCM, Mr. Drevno held COO and leadership positions with Urban Villages, Accenture and General Electric where he was responsible for developing and leading global operating teams.

Mr. Drevno earned a Bachelor of Science in Business and Economics from California State University.

Christy Crase is the Senior Vice President and General Counsel. Ms. Crase joined PCM in 2019 bringing more than 20 years of legal experience.

Prior to joining PCM, Ms. Crase was the Associate General Counsel of Payor and Commercial Contracting at DaVita. Previously, she held leadership positions with Baxter and Gambro. Ms. Crase started her legal career with Jones Day.

Ms. Crase earned a Bachelor of Arts in Political Science, and Spanish from Regis University, and a Juris Doctor Degree from Texas Tech School of Law.

Jeff Huntsman is the Chief Commercial Officer, responsible for the overall commercial strategy and revenue generation for the research division which consists of PCM Trials and EmVenio Research. Mr. Huntsman joined PCM Trials in 2024 with more than 30 years of experience in the Life Sciences space, where he has led global commercial teams selling pharma services solutions across the clinical development and regulatory lifecycle.

Prior to joining PCM Trials, Mr. Huntsman ran a consulting firm providing strategic advice to private equity, venture capital and emerging growth companies. Earlier in his career, he was the Chief Commercial Officer at Sitero, Citeline, ConnectiveRx, and LIQUENT. He has held executive leadership roles at Clarivate, Parexel, Thomson Reuters, and Rogers Communications as well as having served as a Health Care Advisor at Warburg Pincus and Growth Capital Partners.

Mr. Huntsman earned a Bachelor of Science in Marketing and Political Science from Ball State University in Muncie, Indiana.

Mark McKenzie, M.D. is the Chief Medical Officer responsible for strategies and new initiatives in the clinical and therapeutic areas. He also provides medical and clinical oversight to EmVenio’s team of principal investigators involved in trials at community research sites globally. Dr. McKenzie joined EmVenio Research in 2023 with more than 20 years of experience facilitating clinical trials.

Prior to joining EmVenio Research, Dr. McKenzie served as Vice President of Clinical Affairs at M-3 Wake Research, where he was responsible for clinical operations, marketing, business development, and regulatory affairs. Previously, he was the regional medical director and principal investigator at ClinSearch.

Dr. McKenzie earned a Bachelor of Arts in Biology from Southern Adventist University and later returned to earn a Bachelor of Science in medical technology. He then received his doctorate from the Medical College of Ohio at the University of Toledo.

Thad Wolfman is the Chief Strategy Officer. Mr. Wolfman joined PCM Trials through its acquisition of EmVenio Research in early 2024, bringing over two decades of expertise in clinical trials, healthcare, and the pharmaceutical industry. In his previous role as President at EmVenio Research, he focused on the growth of hybrid and decentralized trial capabilities and increased clinical trial diversity inclusion, improving the health and lives of patients.

Before joining EmVenio, Mr. Wolfman served as Executive Director of Corporate Strategy and Development at PPD, leading several initiatives focused on disruption and the future of clinical trials. He also held various senior leadership positions in consulting centered on science and research at EY and PA Consulting Group. Mr. Wolfman earned his MBA in Innovation and Strategic Management from Rensselaer Polytechnic Institute – The Lally School of Management, an MS in Industrial Microbiology / Medical Microbiology from Michigan State University, and a BS in Microbiology and Molecular Genetics from Michigan State University.

Tajuana Barron is the Vice President of Project Management responsible for project delivery. Ms. Barron joined PCM Trials in 2022 with over 30 years of clinical research experience working for Pharma companies and CROs.

Prior to joining PCM Trials, Ms. Barron served as a Senior Director of Project Management at PPD, where her responsibilities included oversight of a strategic partnership, DCT strategy and management of a team of project directors and managers. Previously, she held leadership roles at PRA and Schering Plough Research Institute. Ms. Barron earned a Bachelor of Science in Chemistry from Bennett College and studied at the University of Medicine & Dentistry of New Jersey.

Meghann Howland is the Vice President of Clinical Operations-Global Clinical Trials and joined PCM Trials in January 2024. Ms. Howland joins PCM with over 30 years of experience in healthcare, global trial delivery, and strategy. Prior to joining PCM Trials, Ms. Howland was the Vice President and Head of Clinical Operations at the Pancreatic Cancer Action Network (PanCan) and previously held positions of leadership at mid to large-size CROs, including global therapeutic area head positions in CNS/Psychiatry and Early Phase Oncology. Her foundation in research was established as a board-certified emergency nurse who practiced in a Level II trauma center and went on to lead a research department conducting critical care studies. As a Duke University scholarship recipient, Ms. Howland earned her nursing degree from Watts School of Nursing in 1994 and is currently pursuing her Master of Nursing Education at Purdue University.

Jennifer Hoffman is the Vice President of Human Resources and Talent Acquisition. She joined PCM Trials in 2019 overseeing recruiting, benefits, and human resources.

Prior to joining PCM Trials, Ms. Hoffman was Senior Vice President of Human Resources for Spectrum Retirement Communities. Prior to that, she led a variety of human resource functions at MGM Resorts International and Caesars Entertainment.

Ms. Hoffman earned a Bachelor of Science in Communications from the University of Utah and is certified in Myers-Briggs.